AMI group:none

4 trials

Sponsors

Shengjing Hospital of China Medical University, The Affiliated Changzhou No.2 People's Hospital of Nanjing Medical University, The First Affiliated Hospital of Nanjing Medical University, Zhengzhou Central Hospital

Conditions

Acute myocardial infarctionacute heart failure

Early Phase 1

Predictive value of IL-17A, S100A8/9 and IGFBP5 in patients with initial acute myocardial infarction

RecruitingChiCTR2300069463

The First Affiliated Hospital of Nanjing Medical UniversityAcute myocardial infarction

Start: 2021-02-01Updated: 2023-05-29

miR-143-3p alleviates inflammatory response and myocardial injury after myocardial infarction by inhibiting ADAM17 expression

Active, not recruitingChiCTR2500109497

Zhengzhou Central HospitalAcute myocardial infarction

Start: 2025-10-01Updated: 2025-09-22

Phase 4

Efficacy and safety of levosimendan in improving acute heart failure after acute myocardial infarction based on proteomics and transcriptomics

RecruitingChiCTR2100045062

Shengjing Hospital of China Medical Universityacute heart failure

Start: 2021-05-01Updated: 2021-11-08

Unknown Phase

A clinical study about the prognostic value of cardiac myosin binding protein C in acute myocardial infarction

Active, not recruitingChiCTR2300069171

The Affiliated Changzhou No.2 People's Hospital of Nanjing Medical UniversityAcute myocardial infarction

Start: 2023-03-01Updated: 2023-05-22

Related Papers

The Effectiveness of Remote Exercise Rehabilitation Based on the “SCeiP” Model in Homebound Patients With Coronary Heart Disease: Randomized Controlled Trial

Journal of Medical Internet Research2024-09-244 citations